Clinical trials: Erysipelas, open to volunteers
Erysipelas
Comparing Short to Standard Amoxicillin Course for Erysipelas
Erysipelas is an acute streptococcal skin infection, primarily affecting the lower limbs and easily diagnosed. In 2000, the French expert consensus conference validated oral amoxicillin at 3 to 4.5 gr per day for 10 to 20 days as…
- Trial name
- SHAREII (NCT07104552)
- Testing
- Course of amoxicillin
- Volunteers
- 656 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Cystitis, Erysipelas
Hospital at Home for Elderly Acute Ill Patients
Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization.
- Conditions
- Cystitis, Erysipelas, Pneumonia
- Trial name
- NCT05360914
- Testing
- Hospital at Home (HaH) treatment, Standard hospital admission
- Where
- 3 sites in Denmark
- Volunteers
- 849 people
- Sponsor
- Defactum, Central Denmark Region
Recurrent Erysipelas
Prophylaxis of Recurrent Erysipelas in Lower Limbs: compreSsion thErapy vs aNTibiotics and Compression Therapy.
Erysipelas (superficial cellulitis) is a frequent streptococcal bacterial infection. Each episode of erysipelas may worsen preexisting lymphedema and evolve to life-threatening necrotizing soft-tissue infection.
- Trial name
- PRESENT (NCT07549594)
- Testing
- elastic stockings, Phenoxymethylpenicillin
- Where
- 25 sites in France
- Volunteers
- 200 people
- Sponsor
- University Hospital, Tours